Development of a safe and effective toxin-based gene therapy for the liver cancer
February 21, 2020
Hepatocellular carcinoma (HCC) is one of the liver cancer and related to the various liver diseases. Since the tumor is consist of the highly heterogeneous tumor cells and conventional therapies show insufficient efficacy, a development of the new therapeutic options is an unmet clinical needs.
Senior Lecturer Kenya Kamimura, Professor Shuji Terai, and their research group at the Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences has developed a novel toxin-based gene therapy for HCC and demonstrated its effectiveness and safety in a joint study with Professor Hiroshi Nishina and colleagues at the Department of Developmental and Regenerative Biology, Medical Research Institute of Tokyo Medical and Dental University, and Professor Masato Ohtsuka and colleagues at the Department of Molecular Life Sciences, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine.
Publication Details
Title:?Effect of Diphtheria Toxin-Based Gene Therapy for Hepatocellular Carcinoma
Journal:?Cancers
Authors:?Kenya Kamimura*, Takeshi Yokoo, Hiroyuki Abe, Norihiro Sakai, Takuro Nagoya, Yuji Kobayashi, Masato Ohtsuka, Hiromi Miura, Akira Sakamaki, Hiroteru Kamimura, Norio Miyamura, Hiroshi Nishina, Shuji Terai
*: corresponding author
More 篮球比分直播
-
Newly discovered role of amyloid precursor protein (APP) in nuclear waste disposal
Research results
-
iPatax: a Tablet-based Tool for Quantitative Assessment of Cerebellar Ataxia
Research results
-
Scg2 drives corticospinal circuit reorganization with spinal premotor interneurons and astrocytes for motor recovery after stroke in mice.
Research results
-
A newly discovered kofun (ancient Japanese burial mound) on a forested hillslope in the Kamigiri of Nagaoka City via topographical surveying using an uncrewed aerial vehicle (UAV)
Research results